May 2026 Health Care Technology Standards: Medical Beds, Infusion Containers, and Clinical Study Guidance

With the rapid evolution of health care technology, staying up-to-date with the latest international standards is critical for patient safety, product innovation, and regulatory compliance. In May 2026, five new standards have been published to address safety, performance, and clinical effectiveness across several aspects of medical devices and practice—ranging from medical beds and plastic infusion containers to precise requirements for Traditional Chinese medicine prescriptions. These internationally recognized specifications play a central role in supporting manufacturers, hospitals, clinicians, researchers, and quality managers in the global health care sector.

Overview

The health care technology sector encompasses a wide array of medical products, devices, and protocols essential to patient care, device safety, and treatment efficacy. International standards in this domain establish common requirements, terminology, and testing procedures—driving improvements in human health, clinical outcomes, and patient protection. Through harmonized standards, manufacturers and providers can ensure their devices and practices are both effective and safe, supporting compliance across borders and facilitating market access.

This article outlines the key technical features, compliance needs, and industry impact of five newly released standards in the health care technology field for May 2026. Here, you'll find:

• Thorough breakdowns of new specifications for medical beds, intravenous infusion containers, contraceptive devices, and Traditional Chinese medicine prescriptions
• Practical guidance on adoption, implementation, and regulatory alignment
• Insights into compliance, risk management, and future considerations for your organization

Detailed Standards Coverage

EN ISO 15747:2026 - Plastic Containers for Intravenous Injections (CEN)

Plastic containers for intravenous injections (ISO 15747:2026)

This standard sets forth comprehensive requirements for the safe handling, physical, chemical, and biological testing of plastic containers used for parenteral (infusion or injection) solutions. Applicable to single and multi-chamber plastic containers, such as film bags and blow-molded bottles with nominal capacities from 50 mL to 5,000 mL, this specification ensures that infusion containers used for direct administration meet stringent criteria for patient safety and performance.

Scope & Key Requirements:

• Covers both empty and filled containers, emphasizing compatibility with the manufacturing process (including sterilization)
• Specifies tests for temperature and pressure resistance, leakage, durability (drop resistance), transparency, and water vapor permeability
• Includes requirements for contamination limits, access port integrity (penetration and adhesion strength), and microbial impermeability
• Addresses chemical composition and biological interactions with pharmaceuticals
• Sustainability is highlighted with recommendations on environmentally responsible materials and manufacturing (Annex F)
• Variable and attribute testing guidance in Annex G ensures robust quality assurance programs

Who Should Comply:

• Medical device manufacturers (infusion containers)
• Hospitals and health care facilities
• Procurement and quality assurance departments

Implementation Implications: Organizations should update their design, testing, and QA processes to meet physical, chemical, and biological requirements. Adopting these guidelines also helps facilitate acceptance in markets with strict regulatory controls and pharmacopoeial standards.

Key highlights:

• Resistance to leakage, temperature change, and physical impact
• Biological safety and contamination prevention
• Detailed testing strategies for sustainability and compliance

Access the full standard:View EN ISO 15747:2026 on iTeh Standards

IEC 80601-2-52:2026 - Medical Beds for Adults (ISO)

Medical electrical equipment — Part 2-52: Particular requirements for the basic safety and essential performance of medical beds for adults

This internationally harmonized standard defines basic safety and essential performance requirements for medical beds intended for adult use, encompassing both electrical and nonelectrical (manual) beds, with or without adjustable functions. It applies to beds used in various environments (hospital, long-term care, psychiatric care) and covers both integral beds and platform components used in combination with conventional frames.

Scope & Key Requirements:

• Extensive risk management strategies ensuring patient safety, especially for entrapment and falls
• Requirements for construction robustness, mechanical and electrical safety, stability under load, and hygienic maintenance
• Explicit markings and documentation needed for correct assembly, usage, and cleaning
• Lays out testing for side rail integrity, gap measurements, lateral/longitudinal stability, safe working load, and resistance to unwanted movement
• Integrates psychiatric care environments with special design considerations (new in this edition)
• Cites compatibility with other standards in the IEC 60601 family to guide overall risk reduction

Who Should Comply:

• Manufacturers and distributors of medical beds
• Health care facility managers and purchasing teams
• Maintenance, safety, and compliance personnel

Implementation Implications: The standard compels device manufacturers to implement risk analysis in product development, align labeling/documentation, and verify that products will not pose hazards such as entrapment or tip-over. Facilities procuring new beds benefit by confirming compliance with this standard, reducing risk of adverse events and aiding regulatory approval.

Key highlights:

• New application environments for psychiatric and mental health care
• Updated test protocols for snagging and stability
• Focus on clear labeling and maintenance instructions

Access the full standard:View IEC 80601-2-52:2026 on iTeh Standards

ISO 11249:2026 - Copper-Bearing Intrauterine Contraceptive Devices: Clinical Study Guidance

Copper-bearing intrauterine contraceptive devices — Guidance on the design, execution, analysis and interpretation of clinical studies

For manufacturers, researchers, and regulatory authorities involved in the development or evaluation of copper-bearing intrauterine devices (IUDs), this standard provides essential guidance for planning and conducting clinical studies. It aligns study execution and reporting with ISO 14155, offering frameworks for gathering scientifically robust, credible performance and safety data.

Scope & Key Requirements:

• Guidance on trial design including objectives, ethical considerations, informed consent, and good clinical practice
• Comprehensive criteria for participant selection, risk assessment, and statistical methodology
• Advice on collecting, analyzing, and interpreting safety and efficacy data for IUDs
• Specifies endpoints, adverse event management, and reporting, with templates and best practices
• Recommends complementing this guidance with additional ISO and national regulations (e.g., participant compensation, confidentiality)

Who Should Comply:

• Medical device researchers
• Regulatory affairs professionals
• Clinical investigation sponsors and monitors

Implementation Implications: Using the guidelines helps organizations structure clinical studies that meet international scrutiny, reducing approval risks and maximizing the validity of trial data for product registrations worldwide.

Key highlights:

• Strong focus on clinical study ethics and data integrity
• Harmonization with ISO 14155 requirements
• Inclusion/exclusion criteria and statistical planning for effective trials

Access the full standard:View ISO 11249:2026 on iTeh Standards

ISO 15747:2026 - Plastic Containers for Intravenous Injections (ISO)

Plastic containers for intravenous injections

Serving as the ISO counterpart to EN ISO 15747:2026, this newly revised edition sets out mandatory requirements for plastic containers used in intravenous therapy. The document consolidates and updates terminology, strengthens alignment to modern safety and risk management frameworks, and incorporates environmentally conscious recommendations.

Scope & Key Requirements:

• Applies to medical-grade plastic containers, ensuring they meet robust criteria for chemical compatibility, sterility, and integrity
• Resistance to temperature fluctuation, pressure, impact, and leakage are among the mandatory tests
• Imposes detailed controls on particulate and microbial contamination
• Annex F emphasizes sustainability, encouraging manufacturers to minimize their ecological footprint
• Differences from the previous edition include updated test workflows, clarified terminology (needle versus cannula), and reference to new pharmacopoeias

Who Should Comply:

• Infusion device manufacturers, OEMs, and contract manufacturers
• Laboratories and quality assurance managers in the health sector

Implementation Implications: Testing, materials selection, and documentation should be reviewed to ensure compliance with the strict new requirements. Sustainability considerations provide a roadmap for greening your supply chain without sacrificing product quality.

Key highlights:

• Clear requirements for sustainable design and quality assurance
• Expanded guidance on physical, chemical, and biological testing
• Updated language improves clarity and regulatory confidence

Access the full standard:View ISO 15747:2026 on iTeh Standards

ISO/TS 24943:2026 - Requirements for Decoction Pieces Prescription in Traditional Chinese Medicine

Traditional Chinese medicine — Requirements for decoction pieces prescription

Bridging traditional practice with modern requirements, this technical specification establishes detailed requirements for the prescription of decoction pieces—raw herbal materials prepared and dispensed for use in Traditional Chinese medicine (TCM). The standard promotes medication safety, consistency, and traceability by standardizing how such prescriptions are written, reviewed, and maintained.

Scope & Key Requirements:

• Guidance on prescription writing qualifications, prescription content and format, review, and storage
• Defines the responsibilities of TCM doctors, prescription reviewers, and dispensing personnel
• Stipulates best practices for handling precious, toxic, and narcotic medicines within TCM protocols
• Establishes protocols for revising and archiving prescriptions and for adapting requirements to local regulations
• Includes recommendations for electronic record adoption and supporting information requirements

Who Should Comply:

• Practitioners and pharmacies specializing in Traditional Chinese medicine
• Health care institutions incorporating TCM services
• Regulatory and quality managers overseeing alternative medicine

Implementation Implications: Health care providers must ensure prescription protocols align with the standardized structure and responsibility framework for improved patient safety and regulatory reporting.

Key highlights:

• Comprehensive prescription content and format requirements
• Protocols for high-risk, precious, and controlled herbal items
• Embedded traceability and error reduction throughout TCM pharmacy practice

Access the full standard:View ISO/TS 24943:2026 on iTeh Standards

Industry Impact & Compliance

The release of these international standards marks significant progress in standardizing best practices across critical areas of health care technology. With growing cross-border health delivery, product complexity, and regulatory demands, these standards bring measurable benefits:

• Improved Patient Safety: Requirements enforce robust risk management and product testing, leading to fewer adverse events.
• Regulatory Alignment: Easier global market access and reduced time-to-market for compliant devices.
• Operational Efficiency: Standardized protocols simplify manufacturing, procurement, and maintenance processes.
• Quality Assurance: Clearer benchmarks support better QA programs, supplier evaluation, and device validation.

Compliance Considerations: Organizations should assess current product lines and documentation, initiate gap analyses, and plan for internal training, supplier updates, and any necessary recertification. Compliance timelines may depend on local or national regulations that adopt or reference these international standards—engaging early with regulatory bodies and notified parties is recommended.

Risks of Non-Compliance:

• Regulatory penalties, market access barriers, and supply interruptions
• Heightened liability for product recalls and patient safety incidents
• Reduced competitiveness in international tenders and public procurement

Technical Insights

Across these standards, several common technical requirements and practices emerge:

• Rigorous Testing Protocols: Physical, chemical, and biological tests are specified for materials and finished devices to safeguard against leaks, contamination, and equipment failure.
• Documentation and Traceability: Emphasis on detailed marking, prescription records, and clinical reporting to aid traceability and post-market surveillance.
• User Safety and Environment: Protocols address device-user-interface safety (e.g., in medical beds) and environmental sustainability, encouraging eco-friendly choices throughout the product lifecycle.
• Testing & Certification: Type testing, ongoing QA, and alignment with ISO, IEC, and pharmacopoeial references ensure products remain reliable throughout their operational lifespan.
• Best Practices for Implementation:
  1. Perform gap analysis against current processes and devices
  2. Update design and manufacturing documentation
  3. Validate and document all required tests
  4. Train staff on new standard requirements
  5. Engage with suppliers and regulatory authorities early
  6. Integrate sustainability and risk management for long-term compliance

Conclusion & Next Steps

The May 2026 collection of standards sets the pace for global excellence in health care technology. By adopting these standards, organizations strengthen their commitment to safety, efficacy, and responsible innovation.

Key takeaways:

• Heightened safety and technical rigor for medical beds and infusion containers
• Stronger clinical research protocols for contraceptive devices
• Modernized, traceable requirements for Traditional Chinese medicine prescriptions
• Integrated guidance for sustainability and environmental responsibility

Recommendations:

1. Review the full text of standards via iTeh Standards (https://standards.iteh.ai)
2. Initiate cross-functional teams to assess gap and update processes
3. Stay engaged with industry updates as this is Part 2 of a comprehensive three-part series

Stay informed, stay compliant—make these standards part of your organization’s quality-driven toolkit.